Home/Filings/4/0001209191-18-050650
4//SEC Filing

Routti Jorma 4

Accession 0001209191-18-050650

CIK 0000921299other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 4:54 PM ET

Size

10.5 KB

Accession

0001209191-18-050650

Insider Transaction Report

Form 4
Period: 2018-09-10
Routti Jorma
Director
Transactions
  • Sale

    Common Stock

    2018-09-10$57.19/sh4,300$245,917133,240 total
  • Exercise/Conversion

    Common Stock

    2018-09-10$18.34/sh+6,000$110,040137,540 total
  • Sale

    Common Stock

    2018-09-10$57.60/sh1,700$97,920131,540 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-09-106,0006,000 total
    Exercise: $18.34Exp: 2025-06-03Common Stock (6,000 underlying)
Footnotes (4)
  • [F1]Shares sold pursuant to a 10b5-1 plan.
  • [F2]The shares were sold at prices ranging from $56.55 to $57.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The shares were sold at prices ranging from $57.55 to $57.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Fully vested.

Issuer

FIBROGEN INC

CIK 0000921299

Entity typeother

Related Parties

1
  • filerCIK 0001621330

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:54 PM ET
Size
10.5 KB